A Johns Hopkins study reports that adding three urine biomarkers to standard assessments raises the accuracy of predicting deceased donor kidney transplant success from 80% to 86%.
Read More
HPV self-testing at an opioid treatment program raised cervical cancer screening rates, with 90% of eligible patients opting in, according to a study in JAMA Network Open. The approach targets high-risk, underserved populations.
Read More
Craif Inc has raised $34 million in Series D funding to support a US launch of its urine-based cancer test, expand San Diego lab operations, and advance a pancreatic cancer study and regulatory filing in Japan.
Read More
Algocyte has launched the PROXIMA Mobile Health Station, a portable device that uses AI and sensors for at-home blood analysis from finger-prick samples, with UKCA regulatory approval and ongoing evaluation.
Read More
BRAINBox Solutions has secured financing from Pivotal Capital Partners and New Horizon Bank to advance its point-of-care and lab-based concussion diagnostic devices for traumatic brain injury.
Read More